NIH Cuts Grants To Guard Budget

WASHINGTON—NIH is cutting research grants to scientists by as much as 20 percent to keep in step with a Reagan budget proposal that is given little chance of being adopted this year by Congress. Lobbying organizations for the biomedical community are preparing to sue the government to halt what they claim is a violation of the wishes of Congress and of the appropriate procedure to achieve such spending reductions. The administration, believing Congress was overly generous to NIH, wants to

Written byRon Cowen
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Lobbying organizations for the biomedical community are preparing to sue the government to halt what they claim is a violation of the wishes of Congress and of the appropriate procedure to achieve such spending reductions.

The administration, believing Congress was overly generous to NIH, wants to transfer to next year's budget $334 million of the $6.2 billion appropriated for the current fiscal year (see The Scientist, January 26, 1987). The shift in funds would be achieved by awarding 700 fewer new and competing grants and by trimming $218 million from the grants that are awarded or renewed.

Deputy Director William Raub said that NIH had to begin reducing grants awards in January "to ensure the $334 million would be available to be extended" should Congress approve the plan. Waiting until the summer for Congressional approval might force the NIH to make more drastic cuts—up to "30 to 40 percent," Raub ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies